409 related articles for article (PubMed ID: 37318134)
1. Gut microbiota changes associated with
Gonzales-Luna AJ; Carlson TJ; Garey KW
Gut Microbes; 2023; 15(1):2223345. PubMed ID: 37318134
[TBL] [Abstract][Full Text] [Related]
2. Microbiota restoration therapies for recurrent
DuPont HL; DuPont AW; Tillotson GS
Therap Adv Gastroenterol; 2024; 17():17562848241253089. PubMed ID: 38800353
[TBL] [Abstract][Full Text] [Related]
3. Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
Lavoie T; Appaneal HJ; LaPlante KL
Clin Infect Dis; 2023 Dec; 77(Suppl 6):S447-S454. PubMed ID: 38051964
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
5. Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence.
Gonzales-Luna AJ; Carlson TJ; Garey KW
Clin Infect Dis; 2023 Dec; 77(Suppl 6):S487-S496. PubMed ID: 38051970
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent
Wang Y; Hunt A; Danziger L; Drwiega EN
Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786164
[No Abstract] [Full Text] [Related]
7. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent
Wei S; Bahl MI; Baunwall SMD; Dahlerup JF; Hvas CL; Licht TR
Gut Microbes; 2022; 14(1):2084306. PubMed ID: 36519447
[TBL] [Abstract][Full Text] [Related]
8. The role of the gut microbiome in colonization resistance and recurrent
Seekatz AM; Safdar N; Khanna S
Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
[TBL] [Abstract][Full Text] [Related]
9. SER-109 (VOWST
Blair HA
Drugs; 2024 Mar; 84(3):329-336. PubMed ID: 38441806
[TBL] [Abstract][Full Text] [Related]
10. A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent
Chopra T
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):243-253. PubMed ID: 36756869
[TBL] [Abstract][Full Text] [Related]
11. Navigating changes in
Durham SH; Le P; Cassano AT
J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
[No Abstract] [Full Text] [Related]
12. Current and future trends in clostridioides (clostridium) difficile infection management.
Khanna S; Gerding DN
Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
[TBL] [Abstract][Full Text] [Related]
13. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
14. The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660.
Orenstein R
Infect Dis Ther; 2023 Jan; 12(1):1-7. PubMed ID: 36342653
[TBL] [Abstract][Full Text] [Related]
15. Therapeutics for
Khanna S; Voth E
Expert Rev Gastroenterol Hepatol; 2023; 17(9):903-911. PubMed ID: 37606962
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of
Eliakim-Raz N; Bishara J
Hum Vaccin Immunother; 2019; 15(6):1453-1456. PubMed ID: 29781761
[TBL] [Abstract][Full Text] [Related]
17. Microbial ecology between
Kamiya S
Biosci Microbiota Food Health; 2023; 42(4):229-235. PubMed ID: 37791342
[No Abstract] [Full Text] [Related]
18. The development of live biotherapeutics against
Zhang Y; Saint Fleur A; Feng H
Gut Microbes; 2022; 14(1):2052698. PubMed ID: 35319337
[No Abstract] [Full Text] [Related]
19. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
20. Functional profile of host microbiome indicates
Nzabarushimana E; Tang H
Gut Microbes; 2022; 14(1):2135963. PubMed ID: 36289064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]